Literature DB >> 28446802

Reply to 'Use of serum fibroblast growth factor 23 vs. plasma B-type natriuretic peptide levels in assessing the pathophysiology of patients with heart failure'.

Miki Imazu1,2, Hiroyuki Takahama1, Masafumi Kitakaze1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28446802     DOI： 10.1038/hr.2017.59

Source DB:  PubMed          Journal:  Hypertens Res        ISSN： 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  11 in total

1.  Right ventricular function in heart failure with preserved ejection fraction: a community-based study.

Authors:  Selma F Mohammed; Imad Hussain; Omar F AbouEzzeddine; Omar F Abou Ezzeddine; Hiroyuki Takahama; Susan H Kwon; Paul Forfia; Véronique L Roger; Margaret M Redfield
Journal:  Circulation       Date:  2014-11-12       Impact factor: 29.690

2.  FGF23 induces left ventricular hypertrophy.

Authors:  Christian Faul; Ansel P Amaral; Behzad Oskouei; Ming-Chang Hu; Alexis Sloan; Tamara Isakova; Orlando M Gutiérrez; Robier Aguillon-Prada; Joy Lincoln; Joshua M Hare; Peter Mundel; Azorides Morales; Julia Scialla; Michael Fischer; Elsayed Z Soliman; Jing Chen; Alan S Go; Sylvia E Rosas; Lisa Nessel; Raymond R Townsend; Harold I Feldman; Martin St John Sutton; Akinlolu Ojo; Crystal Gadegbeku; Giovana Seno Di Marco; Stefan Reuter; Dominik Kentrup; Klaus Tiemann; Marcus Brand; Joseph A Hill; Orson W Moe; Makoto Kuro-O; John W Kusek; Martin G Keane; Myles Wolf
Journal:  J Clin Invest       Date:  2011-10-10       Impact factor: 14.808

3.  Biomarkers for right-sided heart failure.

Authors:  Masayuki Tanemoto
Journal:  Hypertens Res       Date:  2017-04-27       Impact factor: 3.872

4.  The prognostic use of right heart catheterization data in patients with advanced heart failure: how relevant are invasive procedures in the risk stratification of advanced heart failure in the era of neurohormones?

Authors:  R S Gardner; G Henderson; T A McDonagh
Journal:  J Heart Lung Transplant       Date:  2005-03       Impact factor: 10.247

5.  Serum blood urea nitrogen and plasma brain natriuretic Peptide and low diastolic blood pressure predict cardiovascular morbidity and mortality following discharge in acute decompensated heart failure patients.

Authors:  Chun-Yen Chen; Akemi Yoshida; Masanori Asakura; Takuya Hasegawa; Hiroyuki Takahama; Makoto Amaki; Akira Funada; Hiroshi Asanuma; Hiroyuki Yokoyama; Jiyoong Kim; Hideaki Kanzaki; Masafumi Kitakaze
Journal:  Circ J       Date:  2012-07-04       Impact factor: 2.993

Review 6.  Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure.

Authors:  Claudio Ronco; Mariantonietta Cicoira; Peter A McCullough
Journal:  J Am Coll Cardiol       Date:  2012-07-25       Impact factor: 24.094

7.  Importance of venous congestion for worsening of renal function in advanced decompensated heart failure.

Authors:  Wilfried Mullens; Zuheir Abrahams; Gary S Francis; George Sokos; David O Taylor; Randall C Starling; James B Young; W H Wilson Tang
Journal:  J Am Coll Cardiol       Date:  2009-02-17       Impact factor: 24.094

8.  Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease.

Authors:  Kevin Damman; Vincent M van Deursen; Gerjan Navis; Adriaan A Voors; Dirk J van Veldhuisen; Hans L Hillege
Journal:  J Am Coll Cardiol       Date:  2009-02-17       Impact factor: 24.094

9.  Pathophysiological impact of serum fibroblast growth factor 23 in patients with nonischemic cardiac disease and early chronic kidney disease.

Authors:  Miki Imazu; Hiroyuki Takahama; Hiroshi Asanuma; Akira Funada; Yasuo Sugano; Takahiro Ohara; Takuya Hasegawa; Masanori Asakura; Hideaki Kanzaki; Toshihisa Anzai; Masafumi Kitakaze
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-12       Impact factor: 4.733

10.  FGF23 promotes myocardial fibrosis in mice through activation of β-catenin.

Authors:  Huixin Hao; Xixian Li; Qingman Li; Hairuo Lin; Zhenhuan Chen; Jiahe Xie; Wanling Xuan; Wangjun Liao; Jianping Bin; Xiaobo Huang; Masafumi Kitakaze; Yulin Liao
Journal:  Oncotarget       Date:  2016-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.